POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
harry
Genital Herpes The primary end point was the occurrence of genital HSV disease in all subjects in Study 1 and in HSV-2–seronegative female subjects in Study 2. The log-rank test was used to compare Kaplan–Meier survival curves for the time to occurrence of genital herpes disease (for months 0 through 19). Data on time to events were censored at the time of the subject's last known status. Analyses were performed according to sex and initial HSV serologic status. Vaccine efficacy, with two-sided
September 17, 2018 • usa